Inhibition of SARS-CoV-2 by Highly Potent Broad-Spectrum Anti-Coronaviral Tylophorine-Based Derivatives

Cheng‐Wei Yang(University of Science and Technology of China), Shiow‐Ju Lee(National Health Research Institutes), Han-Chieh Kao(National Taiwan University), Sui‐Yuan Chang(National Taiwan University of Science and Technology), Yi‐Ling Lin(Taichung Veterans General Hospital), Chun‐Che Liao(Institute of Biomedical Sciences, Academia Sinica), Hsing-Yu Hsu(National Health Research Institutes), Guang‐Hao Niu(National Health Research Institutes), Yu-Hau Pang(National Taiwan University), Szu-Huei Wu(National Health Research Institutes), Ruey‐Bing Yang(Institute of Biomedical Sciences, Academia Sinica), Yue‐Zhi Lee(National Health Research Institutes), Tai‐Ling Chao(National Taiwan University), Huey‐Kang Sytwu(National Health Research Institutes), Jiunn-Horng Lin(Agricultural Technology Research Institute), Chun-Ping Chang(Shih Chien University), Chiung-Tong Chen(National Yang Ming Chiao Tung University), Jian-Jong Liang(Institute of Biomedical Sciences, Academia Sinica), Jia-Tsrong Jan(Genomics Research Center, Academia Sinica), Wen-Zheng Huang(Agricultural Technology Research Institute), Tzu-Ting Peng(Agricultural Technology Research Institute)
Frontiers in Pharmacology
December 14, 2020
Cited by 24


Related Papers